BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
377.63
-4.64 (-1.21%)
At close: Oct 23, 2026, 4:00 PM EDT
375.00
-2.63 (-0.70%)
Pre-market: Oct 26, 2026, 7:08 AM EDT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of $42.94 billion as of October 23, 2026. Its market cap has increased by 24.50% in one year.
Market Cap
42.94B
Enterprise Value
39.89B
1-Year Change
24.50%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from $861.90M to $42.94B, an increase of 4,881.70%. That is a compound annual growth rate of 43.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 42.92B | 27.72% |
| Dec 31, 2025 | 33.61B | 70.71% |
| Dec 31, 2024 | 19.69B | 4.41% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
| Feb 3, 2016 | 861.90M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 80.39B |
| Moderna | 79.89B |
| argenx SE | 54.78B |
| Revolution Medicines | 40.08B |
| Royalty Pharma | 36.72B |
| Alnylam Pharmaceuticals | 29.98B |
| Roivant Sciences | 26.36B |
| Genmab | 25.91B |